These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 33104828)

  • 41. Effects of simvastatin on CAT-1-mediated arginine transport and NO level under high glucose conditions in conditionally immortalized rat inner blood-retinal barrier cell lines (TR-iBRB).
    Tun T; Kang YS
    Microvasc Res; 2017 May; 111():60-66. PubMed ID: 28089735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective effects of methane-rich saline on diabetic retinopathy via anti-inflammation in a streptozotocin-induced diabetic rat model.
    Wu J; Wang R; Ye Z; Sun X; Chen Z; Xia F; Sun Q; Liu L
    Biochem Biophys Res Commun; 2015 Oct; 466(2):155-61. PubMed ID: 26363454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes.
    Ibrahim AS; El-Remessy AB; Matragoon S; Zhang W; Patel Y; Khan S; Al-Gayyar MM; El-Shishtawy MM; Liou GI
    Diabetes; 2011 Apr; 60(4):1122-33. PubMed ID: 21317295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular endothelial growth factor-A
    Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
    Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
    Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
    Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model.
    Shin JY; Sohn J; Park KH
    J Korean Med Sci; 2013 Apr; 28(4):608-13. PubMed ID: 23579598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-VEGF effects of intravitreal erythropoietin in early diabetic retinopathy.
    Zhang J; Hu LM; Xu G; Wu Y; Shen J; Luo Y; Zhong Y; Sinclair SH; Yanoff M; Li W; Xu GT
    Front Biosci (Elite Ed); 2010 Jun; 2(3):912-27. PubMed ID: 20515763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Consumption of Polyphenol-Rich Zingiber Zerumbet Rhizome Extracts Protects against the Breakdown of the Blood-Retinal Barrier and Retinal Inflammation Induced by Diabetes.
    Tzeng TF; Hong TY; Tzeng YC; Liou SS; Liu IM
    Nutrients; 2015 Sep; 7(9):7821-41. PubMed ID: 26389948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
    Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling.
    Long L; Li Y; Yu S; Li X; Hu Y; Long T; Wang L; Li W; Ye X; Ke Z; Xiao H
    J Diabetes Res; 2019; 2019():4875421. PubMed ID: 31976335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy.
    Rangasamy S; McGuire PG; Franco Nitta C; Monickaraj F; Oruganti SR; Das A
    PLoS One; 2014; 9(10):e108508. PubMed ID: 25329075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.
    Al-Shabrawey M; Bartoli M; El-Remessy AB; Ma G; Matragoon S; Lemtalsi T; Caldwell RW; Caldwell RB
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3231-8. PubMed ID: 18378570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
    Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The emerging roles of clusterin on reduction of both blood retina barrier breakdown and neural retina damage in diabetic retinopathy.
    Zhang C; Nie J; Feng L; Luo W; Yao J; Wang F; Wang H
    Discov Med; 2016 Apr; 21(116):227-37. PubMed ID: 27232509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
    Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early Microglial Changes Associated with Diabetic Retinopathy in Rats with Streptozotocin-Induced Diabetes.
    Park YG; Lee JY; Kim C; Park YH
    J Diabetes Res; 2021; 2021():4920937. PubMed ID: 34926698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term treatment with suberythropoietic Epo is vaso- and neuroprotective in experimental diabetic retinopathy.
    Wang Q; Gorbey S; Pfister F; Höger S; Dorn-Beineke A; Krügel K; Berrone E; Wu L; Korff T; Lin J; Busch S; Reichenbach A; Feng Y; Hammes HP
    Cell Physiol Biochem; 2011; 27(6):769-82. PubMed ID: 21691094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-Talk between Sirtuin 1 and the Proinflammatory Mediator High-Mobility Group Box-1 in the Regulation of Blood-Retinal Barrier Breakdown in Diabetic Retinopathy.
    Mohammad G; Abdelaziz GM; Siddiquei MM; Ahmad A; De Hertogh G; Abu El-Asrar AM
    Curr Eye Res; 2019 Oct; 44(10):1133-1143. PubMed ID: 31136205
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.
    El-Remessy AB; Al-Shabrawey M; Khalifa Y; Tsai NT; Caldwell RB; Liou GI
    Am J Pathol; 2006 Jan; 168(1):235-44. PubMed ID: 16400026
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy.
    McVicar CM; Hamilton R; Colhoun LM; Gardiner TA; Brines M; Cerami A; Stitt AW
    Diabetes; 2011 Nov; 60(11):2995-3005. PubMed ID: 21911748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.